Recently, the United States president Donald Trump has signed the National Defense Authorization Act for Fiscal Year 2020 which allows Trump to impose sanctions on corporations and individuals that involved in the construction of Nord Stream 2 and TurkStream project. The action makes quite a few Europeans who regard themselves as allies with Americans feel hurt.
-
Recently, the United States president Donald Trump has signed the National Defense Authorization Act for Fiscal Year 2020 which allows Trump to impose sanctions on corporations and individuals that involved in the construction of Nord Stream 2 and TurkStream project. The action makes quite a few Europeans who regard themselves as allies with Americans feel hurt.
-
Scientists are currently working on the launch of the Tianqin-2 satellite to test key technologies for space-based gravitational wave detection. These include the main technologies for use in next-generation gravity satellites.
-
A rock core that was drawn out on August 4, 2020, from Namtso Lake, China's third-largest salt lake, is expected to unveil Qinghai-Tibet Plateau's meteorological and environmental changes over the past 150,000 years.
Brazilian researchers have discovered one of the causes of severe COVID-19 in diabetic patients. Laboratory experiments showed that the higher level of blood sugar in these patients is captured by monocytes, a type of defense cell, and serves as a source of additional energy for the coronavirus to replicate more than in a healthy organism. In response to the increased viral load, the monocytes release large amounts of pro-inflammatory cytokines with several effects including lung cell death.
-
China is a model for making its vision to lead global innovation.China leads the development of infrastructure for an advanced technological environment, and the number of its people’s use of technologies and applications increases every year. In many fields, China is also a role model for global innovation.
-
The Chinese Consulate General in Los Angeles on April 10 invited Zhang Boli, an academician of the Chinese Academy of Engineering and president of Tianjin University of Traditional Chinese Medicine, to speak live over the internet with students and overseas Chinese in the U.S. on how to use Traditional Chinese Medicine (TCM) to prevent and treat COVID-19.
-
Around the time of the 2020 Spring Festival, Ma Juncai, a researcher at the Institute of Microbiology, Chinese Academy of Sciences (CAS), and Wei Qiang from the Chinese Center for Disease Control and Prevention (China CDC), got together to brainstorm ideas about how to develop a support system for COVID-19 related research by leveraging strengths of both sides.
-
According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.
Beijing Municipal People's Government, National Development and Reform Commission, the Ministry of Science and Technology and the Ministry of Industry and Information Technology will jointly hold the first World 5G Convention in Beijing Economic-Technological Development Area from November 20 to 23, 2019. The Convention aims to seize the opportunities brought by 5G technological innovation and industry reform, collect quality innovation resources and advance the growth and application of 5G. It also intends to expedite the commercialization of 5G and boost the exchange and joint advances of global 5G technologies.
Roxadustat, a new drug used for treating anemia of chronic kidney disease, has recently been recognized by top international academia. It is expected to lead the revolutionary change in the treatment mode of renal anemia.
In the preliminary meeting of operating the regional research center, International Centre for Genetic Engineering Biotechnology (ICGEB) in China, Science and Technology Daily was informed that China Medical City (CMC), China's leading medical industrialization base in Taizhou, Jiangsu Province, was invited by ICGEB to discuss the promotion and collaboration between CMC and ICGEB.
